Overexpression of IL-22 by gene targeting or delivery through adenovirus expressing IL-22 has previously been shown to reduce liver fibrosis and accelerate fibrosis resolution during recovery in the carbon tetrachloride (CCl4) model19,24. The gene discussed is IL22; the disease is Hepatic fibrosis.